Oramed Pharmaceuticals (NASDAQ:ORMP) Downgraded to Sell Rating by StockNews.com
StockNews.com lowered shares of Oramed Pharmaceuticals (NASDAQ:ORMP – Free Report) from a hold rating to a sell rating in a research note published on Wednesday morning. Oramed Pharmaceuticals Trading Down 1.7 % Shares of ORMP opened at $2.33 on Wednesday. Oramed Pharmaceuticals has a 12 month low of $2.00 and a 12 month high of […]
StockNews.com lowered shares of Oramed Pharmaceuticals (NASDAQ:ORMP – Free Report) from a hold rating to a sell rating in a research note published on Wednesday morning. Oramed Pharmaceuticals Trading Down 1.7 % Shares of ORMP opened at $2.33 on Wednesday. Oramed Pharmaceuticals has a 12 month low of $2.00 and a 12 month high of […]
